Patients with moderate-to-severe plaque psoriasis have lower fertility rates and higher risk of pregnancy loss than women with psoriasis.

Dr. Ron Vender discusses the late breaking study of an oral peptide to treat moderate-to-severe psoriasis at WCD2023 in Singapore.

Dr. Ron Vender reviews critical IPC presentations from WCD2023 in Singapore.

Dr. Ron Vender gives an overview of the International Psoriasis Council Councilor Meeting at WCD2023 in Singapore.

Tildrakizumab is linked to improved QoL and sleep in patients with moderate-to-severe plaque psoriasis.

Exposure to biologics during pregnancy and conception does not increase the risk of adverse events in pregnant psoriasis patients.

Lower limbs are the hardest to treat with narrowband-UVB therapy on patients with chronic plaque psoriasis.

Psoriasis patients being treated with acitretin are at a greater risk of developing psychiatric disorders.